A generic drug for allergy symptoms showed signs that it may help patients with multiple sclerosis rebuild their eye nerves, offering a possible over-the-counter path to treat a disease now addressed with therapies from companies such as Biogen Inc.
Patients on the drug, called clemastine fumarate, sent signals between the eyes and the brain faster than those on placebo in a mid-stage study, according to a statement Tuesday from the American Academy of Neurology. That suggests the drug may be helping repair nerves that are damaged in some patients with multiple sclerosis.
“This was a statistically significant effect for people for the period they were on therapy, and not just marginally,” said Ari Green, the study’s lead author and medical director of the University of California at San Francisco’s Multiple Sclerosis Center. “This is a start down a very difficult path towards neural repair in multiple sclerosis.”
FULL ARTICLE: http://www.bloomberg.com/news/articl...id-stage-trial
Patients on the drug, called clemastine fumarate, sent signals between the eyes and the brain faster than those on placebo in a mid-stage study, according to a statement Tuesday from the American Academy of Neurology. That suggests the drug may be helping repair nerves that are damaged in some patients with multiple sclerosis.
“This was a statistically significant effect for people for the period they were on therapy, and not just marginally,” said Ari Green, the study’s lead author and medical director of the University of California at San Francisco’s Multiple Sclerosis Center. “This is a start down a very difficult path towards neural repair in multiple sclerosis.”
FULL ARTICLE: http://www.bloomberg.com/news/articl...id-stage-trial